Back to Search Start Over

Outcomes of a cardiothoracic intensive care web-based online intravenous insulin infusion calculator study at a Medical University Hospital

Authors :
Kathie L. Hermayer
Diane E. Neal
Michael G. Irving
John M. Kratz
Timothy V. Hushion
Pamela C. Arnold
Frank B. Kerr
Martha R. Stroud
Lisa Kozlowski
Source :
Diabetes technologytherapeutics. 9(6)
Publication Year :
2007

Abstract

The purpose of this study was to examine whether a web-based, on-line intravenous insulin (IVI) infusion calculator (IVIIC) program for the delivery of IVI therapy in coronary artery bypass graft (CABG) patients was superior to a prior IVI protocol used in the cardiothoracic intensive care unit at our institution.The study included 97 CABG patients studied from October 2004 to February 2005 pre-protocol (type 2 diabetes) and October 2005 to February 2006 post-protocol (with or without type 2 diabetes). The IVIIC was programmed to resemble an algorithm whereby any patient with type 2 diabetes or a blood glucose (BG) greater than 120 mg/dL was started on IVI with an insulin sensitivity factor, a multiplier of 0.03. The calculator used the following mathematical formula: rate of insulin infusion/hour = (current BG - 60 mg/dL) x 0.03.Pre- and post-protocol groups for patients with type 2 diabetes were similar in all demographics measured, including initial age, mean age, percentage female, and percentage African-American. Significant differences were observed between pre- and post-protocol groups in mean BG recorded over a 48-h period (P0.0001), percentage not at target within 48 h (P0.0001), mean hours to first BG between 80 to 120 mg/dL (P0.0001), mean hours to target (three consecutive BGs 80-120 mg/dL) (P0.0001), and hyperglycemic index (P0.0001). The incidence of hypoglycemia (percentage BG70 mg/dL) was not significantly increased in the post-protocol groups (P = 0.2581).We conclude that the IVIIC is a safe nurse-driven protocol with excellent BG outcomes.

Details

ISSN :
15209156
Volume :
9
Issue :
6
Database :
OpenAIRE
Journal :
Diabetes technologytherapeutics
Accession number :
edsair.doi.dedup.....01a9371cd3a0d4900c335730546ddaa6